Close Menu

liver biopsy

The Diagnostic Value of FibroScan in Assessing Significant Liver Fibrosis in Patients with Chronic Hepatitis B

Issue: 
DOI: 
10.7727/wimj.2014.150
Pages: 
106–10
Synopsis: 
This study assesses the value of Fibroscan and fibrosis serum models, including aspartate transaminase to platelet ratio index (APRI), in predicting significant liver fibrosis in patients with chronic hepatitis B infection compared with liver biopsy.

ABSTRACT

Objective: Significant liver fibrosis is recognized as the key link of therapy and prognosis in patients with chronic hepatitis B infection (CHB). The present study is designed to estimate the benefits of FibroScan (FS) in diagnosing significant fibrosis in patients with CHB.

Accepted: 
30 Jun, 2014
PDF Attachment: 
Journal Sections: 
e-Published: 15 May, 2015
Subscribe to RSS - liver biopsy
Top of Page